Andere Sprachen Instil Bio, Inc.

Aktien

A3E2GE

US45783C2008

TIL

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 18.04.2024			% 5 Tage	% 1. Jan.
10,41 ^USD	-1,65 %		-5,88 %	+36,61 %

12.04.	INSTIL BIO, INC. : Jefferies & Co. ist jetzt neutral	ZM
21.03.	Instil Bio, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

North American Morning Briefing : Stock Futures -2-	15.04.
Instil Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21.03.
Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	21.03.
Instil Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21.03.
Instil Bio Announces Strategic Update	16.01.
Instil Bio, Inc. Enters into Agreement with A Collaboration to Conduct Preclinical Manufacturing Feasibility Studies in the ITIL-306 Program	16.01.
Instil Bio, Inc. Announces the Closure of Its UK Manufacturing and Clinical Operations	16.01.
Instil Bio, Inc.(NasdaqCM:TIL) dropped from NASDAQ Biotechnology Index	15.12.
Instil Bio Says 1-for-20 Reverse Stock Split to Take Effect on Dec. 7	06.12.
Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split	05.12.
Instil Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.
Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update	13.11.
Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting	06.11.
Instil Bio, Inc.(NasdaqCM:TIL) dropped from S&P Global BMI Index	18.09.23
Instil Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14.08.23
Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update	14.08.23
Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference	26.06.23
Instil Bio, Inc. Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference	26.06.23
Instil Bio, Inc.(NasdaqGS:TIL) dropped from Russell Small Cap Comp Value Index	23.06.23
Instil Bio, Inc.(NasdaqGS:TIL) dropped from Russell 3000 Index	23.06.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Instil Bio, Inc.

Aktien

A3E2GE

US45783C2008

TIL

Andere Sprachen

Filter